Category: General Surgery

Radical Resection with Intestinal Autotransplantation Improves Outcomes in Pancreatic Cancer

Surgeons treating locally advanced pancreatic cancer (LAPC) can improve patient survival by using radical resection combined with intestinal autotransplantation after systemic treatment. Patients who underwent radical resection and autotransplantation had a median overall survival of 25.8 months, compared to 14.2 months for those who did not have surgery. Median progression-free survival was also better at […]

Circulating Tumor DNA Predicts Recurrence in Esophageal Cancer

Assessing circulating tumor DNA (ctDNA) in patients with esophageal squamous cell carcinoma (ESCC) identifies high recurrence risk after surgery. Pre-neoadjuvant chemotherapy, ctDNA was detected in 100% of advanced stages and 50% of stage I. Recurrence rates soared to 77.8% in ctDNA-positive patients versus 27.8% in ctDNA-negative patients, with a hazard ratio of 4.56. Consider ctDNA […]

Medicaid Expansion Lowers Death Rate in Colorectal Cancer Patients

Medicaid expansion is linked to improved survival rates in younger colorectal cancer patients with liver metastasis, impacting surgical decision-making. 3-year disease-specific mortality dropped from 75% to 68% in expansion states after 6+ years. Risk of death reduced by 5-10% in expansion states compared to non-expansion, particularly benefiting those who underwent liver metastasectomy (HR 0.71-0.85). Access […]

Language-Savvy Hospitals Cut Readmission for Non-English Patients

Patients with non-English primary languages experience better surgical outcomes at language-serving hospitals compared to non-language-serving ones. Readmission rates were 2.6% at language-serving hospitals versus 5.7% at non-language-serving hospitals (p < 0.001). Patients at language-serving hospitals had a 56% lower chance of readmission (adjusted odds ratio: 0.44). Understanding these differences can guide surgical practices and improve […]

Navigating Neoadjuvant Assessment for Pancreatic Cancer

Assessing neoadjuvant therapy response in pancreatic cancer is crucial for improving surgical outcomes. A 50% decrease in CA19-9 levels correlated with better overall survival (32 months vs 24 months, p = 0.0028). Combining CA19-9 response with major pathologic response was linked to the best survival (40 months, p = 0.0086), though this occurred in only […]

Outcomes of Right and Left 6-Segmentectomies for Liver Tumors

Right (H145678) and Left (H123458) 6-segmentectomies show potential for long-term survival in select patients with malignant liver tumors. Surgical futility occurred in 15.6%, with failure-to-rescue rates at 30.3%. Achieved textbook outcomes in 30.8% of patients, with a median follow-up of 26 months. 5-year overall survival at 30.8% and disease-free survival at 18.9%. Consider targeted strategies […]

Novel Radiation Approach Elevates Outcomes in Locally Advanced Pancreatic Cancer

Hypofractionated ablative radiation therapy before surgery improves overall survival in locally advanced pancreatic cancer. 38% overall survival at 2 years; 54% for those who underwent resection. Only 11% local progression and 73% distant metastasis rates at 2 years. This strategy shows no increase in surgical morbidity, making it significant for patient selection and preoperative planning […]

Survival Advantage with Neoadjuvant Chemotherapy in Esophageal Cancer

Neoadjuvant chemotherapy (NCT) significantly improves long-term survival in patients with esophageal and esophagogastric junction adenocarcinoma compared to chemoradiotherapy (NCRT). Overall survival rates at 1, 3, and 5 years with NCT were 95.4%, 81.5%, and 73.8% versus 87.8%, 64.8%, and 56% for NCRT (p < 0.001). Disease-free survival also favored NCT, with a substantially reduced risk […]

Acute Colonic Ischemia Risks After Colectomy for Cancer

Postoperative colonic ischemia is rare but significantly impacts outcomes after elective colectomy for colorectal cancer. Occurred in 0.27% of patients; highest rates seen in left hemicolectomy (0.52%) and transverse colectomy (0.47%). Patients with ischemia had a median Charlson comorbidity index of 3 versus 2 in those without (p < .001). It is linked to a […]

Hem-o-lok Clips Outperform Endoloops for Appendiceal Closure

Hem-o-lok clips provide a safer and faster option for appendiceal stump closure in laparoscopic appendectomy compared to endoloops. Intra-abdominal abscess formation was 1.87 times less likely with hem-o-lok clips (p=0.035). Operative time was significantly shorter by an average of 5.41 minutes (p=0.019). Surgeons may consider hem-o-lok clips for improved outcomes and efficiency in appendectomies. No […]